Alembic Pharmaceuticals consolidated net profit declines 11.96% in the March 2025 quarter

Sales rise 16.66% to Rs 1769.64 crore

Net profit of Alembic Pharmaceuticals declined 11.96% to Rs 156.89 crore in the quarter ended March 2025 as against Rs 178.21 crore during the previous quarter ended March 2024. Sales rose 16.66% to Rs 1769.64 crore in the quarter ended March 2025 as against Rs 1516.98 crore during the previous quarter ended March 2024.

For the full year,net profit declined 5.26% to Rs 583.42 crore in the year ended March 2025 as against Rs 615.82 crore during the previous year ended March 2024. Sales rose 7.12% to Rs 6672.08 crore in the year ended March 2025 as against Rs 6228.63 crore during the previous year ended March 2024.

 

ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.Sales1769.641516.98 17 6672.086228.63 7 OPM %15.3317.12 -15.1114.97 - PBDT260.94252.33 3 972.88904.50 8 PBT191.95182.85 5 694.30631.83 10 NP156.89178.21 -12 583.42615.82 -5

Powered by Capital Market - Live News